-
The impact of the COVID-19 crisis on the diagnosis and treatment of cancer...
The impact of the COVID-19 crisis on the diagnosis and treatment of cancer patients: lessons for the future.; De impact van de COVID-19 uitbraak op de diagnostiek en behandeling... -
Aanhoudende Klachten na COVID-19: perspectief vanuit de populatie, patient, en zorg.
Aanhoudende Klachten na COVID-19: perspectief vanuit de populatie, patient, en zorg (ACTION) -
The impact of the COVID-19 pandemic on death and bereavement (the CO-LIVE project)
The impact of the COVID-19 pandemic on death and bereavement (the CO-LIVE project) -
Inzicht in aanhoudende klachten na Covid-19 besmetting: een mixed methods benadering
Inzicht in aanhoudende klachten na Covid-19 besmetting: een mixed methods benadering -
CoviChron: Covid-19 and Chronic illness interactions in transmission dynamics
CoviChron: Covid-19 and Chronic illness interactions in transmission dynamics -
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de...
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de Intensive Care (ANACOR-IC) -
Monitoring the evolution spread and transmission of SARS-CoV-2 through whole...
Monitoring the evolution spread and transmission of SARS-CoV-2 through whole genome sequencing to enable fast genotype to phenotype prediction -
A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A...
A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A focus on convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulines -
COVID-19 Follow-up care paths and Long-term Outcomes Within the Dutch health...
COVID-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: a combined rehabilitation, pulmonary, and intensive care perspective -
CounterCOVID study - oral imatinib for COVID-19
CounterCOVID study - oral imatinib for COVID-19 -
Preclinical development of an antiviral small molecule drug against COVID-19
Preclinical development of an antiviral small molecule drug against COVID-19 -
Understanding the two faces of the COVID-19 immune response to predict...
Understanding the two faces of the COVID-19 immune response to predict clinical course and define strategies for early and late phase intervention -
Covid-19 vragenlijstonderzoek naar gedrag en welzijn
Wp3 Cohort vragenlijstonderzoek -
Immunity against SARS-CoV-2 in immune-suppressed patients: increased risk of...
Immunity against SARS-CoV-2 in immune-suppressed patients: increased risk of insufficient immunological memory or sufficient protection against re-infection a a Target to B!... -
Economische Veerkracht van Regio's
Economische Veerkracht van Regio's -
Timing and sequence of vaccination against COVID-19 and Influenza
Timing and sequence of vaccination against COVID-19 and Influenza -
Frequency of opportunistic pathogens in Covid-19 and their impact on clinical outcome
Frequency of opportunistic pathogens in Covid-19 and their impact on clinical outcome -
Ethiek van e-Health tijdens de coronacrisis en daarna: lessen uit de pandemie
Ethiek van e-Health tijdens de coronacrisis en daarna: lessen uit de pandemie -
COVID-NL cohort LUMC
Clinical data of LUMC COVID-NL cohort -
Clinical prediction models for Covid-19: development, international...
Clinical prediction models for Covid-19: development, international validation and use
U kunt ook het register raadplegen met behulp van de API (see API documentatie).